HK inno.N's K-CAB met primary endpoints in a 783-patient U.S. Phase 3 trial, improving heartburn and acid reflux versus placebo.
VOQUEZNA (vonoprazan) is a potassium-competitive acid blocker (PCAB) that reduces stomach acid production. It is approved in the U.S. for adults with erosive GERD, heartburn associated with ...
Detailed analysis from the randomized, double-blind, placebo-controlled Phase 3 TRIUMpH-NERD study demonstrated that both ...
New analysis projects VOQUEZNA® (vonoprazan) to provide meaningful economic value and be cost-effective vs. proton pump inhibitors (PPIs) for ...
Three scientific presentations will highlight new analyses of VOQUEZNA® (vonoprazan) in GERD, including real-world patient characteristics, ...
Benishangul-Gumuz, the western Ethiopian region that hosts the Grand Ethiopian Renaissance Dam (GERD), has long faced a high ...
Infectious disease experts have revealed to the Daily Mail everything to know about a rare form of plague amid outbreak fears ...
A doctor reassures a thyroid cancer patient that radioactive iodine treatment poses minimal risk to organs like the heart and ...
A physician says the procedure has a very high cure rate when combined with surgery for most thyroid cancer types.
Some cancer mutations can block iodine uptake, but the majority of thyroid cancer cases have a high cure rate with ...
Radioactive iodine passes through the heart and stomach quickly, targeting only thyroid and thyroid cancer cells with ...
I recently had a thyroidectomy for thyroid cancer and had my entire thyroid removed. This month, I’m scheduled for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results